214 related articles for article (PubMed ID: 31527799)
41. Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells.
Jian FF; Li YF; Chen YF; Jiang H; Chen X; Zheng LL; Zhao Y; Wang WQ; Ning G; Bian LG; Sun QF
Chin Med J (Engl); 2016 Sep; 129(17):2102-8. PubMed ID: 27569239
[TBL] [Abstract][Full Text] [Related]
42. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.
Wang LL; Wan XY; Liu CQ; Zheng FM
Mol Med; 2022 May; 28(1):49. PubMed ID: 35508987
[TBL] [Abstract][Full Text] [Related]
43. USP8 and PARK2/parkin-mediated mitophagy.
Durcan TM; Fon EA
Autophagy; 2015; 11(2):428-9. PubMed ID: 25700639
[TBL] [Abstract][Full Text] [Related]
44. Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression.
Tian Y; Liu K; Liu R; Qiu Z; Xu Y; Wei W; Xu X; Wang J; Ding H; Li Z; Bian J
J Med Chem; 2022 Jul; 65(13):8914-8932. PubMed ID: 35786929
[TBL] [Abstract][Full Text] [Related]
45. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.
Izrailit J; Jaiswal A; Zheng W; Moran MF; Reedijk M
Oncogene; 2017 Feb; 36(8):1048-1057. PubMed ID: 27593927
[TBL] [Abstract][Full Text] [Related]
46. Biophysical and structural insight into the USP8/14-3-3 interaction.
Centorrino F; Ballone A; Wolter M; Ottmann C
FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
[TBL] [Abstract][Full Text] [Related]
47. Deubiquitinating Enzyme USP8 Is Essential for Skeletogenesis by Regulating Wnt Signaling.
Chaugule S; Kim JM; Yang YS; Knobeloch KP; He X; Shim JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638628
[TBL] [Abstract][Full Text] [Related]
48. EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase.
Kasahara K; Aoki H; Kiyono T; Wang S; Kagiwada H; Yuge M; Tanaka T; Nishimura Y; Mizoguchi A; Goshima N; Inagaki M
Nat Commun; 2018 Feb; 9(1):758. PubMed ID: 29472535
[TBL] [Abstract][Full Text] [Related]
49. USP8 ameliorates cognitive and motor impairments via microglial inhibition in a mouse model of sepsis-associated encephalopathy.
Bi W; Lan X; Zhang J; Xiao S; Cheng X; Wang H; Lu D; Zhu L
Brain Res; 2019 Sep; 1719():40-48. PubMed ID: 31075263
[TBL] [Abstract][Full Text] [Related]
50. The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364.
Tian Y; Liu K; Wu D; Wu L; Xu Q; Wei W; Li Z; Du Q; Bian J
Eur J Med Chem; 2024 Mar; 268():116275. PubMed ID: 38452725
[TBL] [Abstract][Full Text] [Related]
51. Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening.
Han J; Tian Y; Yu L; Zhang Q; Xu X; Zhang Y; Wang J; Ma Z; Bian J; Luo C; Jiang H; Chen K; Zhao Y; Li Z; Ding H
Bioorg Chem; 2020 Aug; 101():103962. PubMed ID: 32480171
[TBL] [Abstract][Full Text] [Related]
52. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
[No Abstract] [Full Text] [Related]
53. USP8--Another DUB in the T cell club.
Dufner A; Knobeloch KP
Cell Cycle; 2015; 14(24):3775-6. PubMed ID: 26697830
[No Abstract] [Full Text] [Related]
54. Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.
Tan L; Shan H; Han C; Zhang Z; Shen J; Zhang X; Xiang H; Lu K; Qi C; Li Y; Zhuang G; Chen G; Tan L
J Med Chem; 2022 Oct; 65(20):13645-13659. PubMed ID: 36221183
[TBL] [Abstract][Full Text] [Related]
55. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
[TBL] [Abstract][Full Text] [Related]
56. A heterozygous germline deletion within USP8 causes severe neurodevelopmental delay with multiorgan abnormalities.
Sakamoto M; Kurosawa K; Tanoue K; Iwama K; Ishida F; Watanabe Y; Okamoto N; Tsuchida N; Uchiyama Y; Koshimizu E; Fujita A; Misawa K; Miyatake S; Mizuguchi T; Matsumoto N
J Hum Genet; 2024 Feb; 69(2):85-90. PubMed ID: 38030753
[TBL] [Abstract][Full Text] [Related]
57. Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT.
Tang J; Long G; Hu K; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
Adv Sci (Weinh); 2023 Nov; 10(33):e2302953. PubMed ID: 37867237
[TBL] [Abstract][Full Text] [Related]
58. Expression and mutational status of
Perez-Rivas LG; Oßwald A; Knösel T; Lucia K; Schaaf C; Hristov M; Fazel J; Kirchner T; Beuschlein F; Reincke M; Theodoropoulou M
Endocr Relat Cancer; 2017 Sep; 24(9):L73-L77. PubMed ID: 28710116
[No Abstract] [Full Text] [Related]
59. Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8).
Avvakumov GV; Walker JR; Xue S; Finerty PJ; Mackenzie F; Newman EM; Dhe-Paganon S
J Biol Chem; 2006 Dec; 281(49):38061-70. PubMed ID: 17035239
[TBL] [Abstract][Full Text] [Related]
60. USP8 inhibition regulates autophagy flux and controls
Santelices J; Ou M; Maegawa GHB; Hercik K; Edelmann MJ
Front Cell Infect Microbiol; 2023; 13():1070271. PubMed ID: 37026055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
